Not so quick. The company stated that interest in hbv was higher than ever and that the TT-034 data is also very important to prospective partners to validate the model.
If we get positive in vivo data released this month it's then see if any partner makes a move before waiting for TT-034 data.
If no partner is interested after the in vivo data you have to question just what are they waiting for?
BLT Price at posting:
13.0¢ Sentiment: None Disclosure: Held